SEDDAIU, Maria Antonietta
 Distribuzione geografica
Continente #
NA - Nord America 1.275
EU - Europa 804
AS - Asia 421
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 1
Totale 2.510
Nazione #
US - Stati Uniti d'America 1.268
CN - Cina 324
UA - Ucraina 310
DE - Germania 112
SE - Svezia 106
IT - Italia 78
FI - Finlandia 52
FR - Francia 47
CZ - Repubblica Ceca 40
GB - Regno Unito 34
TR - Turchia 29
SG - Singapore 27
BE - Belgio 17
ID - Indonesia 16
IR - Iran 9
KR - Corea 7
CA - Canada 6
AU - Australia 5
BD - Bangladesh 3
EU - Europa 3
IN - India 3
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AT - Austria 1
BG - Bulgaria 1
BR - Brasile 1
BT - Bhutan 1
CH - Svizzera 1
EE - Estonia 1
ES - Italia 1
IL - Israele 1
LU - Lussemburgo 1
PA - Panama 1
Totale 2.510
Città #
Chandler 370
Jacksonville 191
Princeton 96
Nanjing 76
Dearborn 75
Ann Arbor 69
Sassari 56
Wilmington 52
Brno 38
Nanchang 37
Boardman 34
Beijing 29
Woodbridge 26
Changsha 25
Izmir 25
Shenyang 25
Tianjin 18
Brussels 17
Zhengzhou 15
Jiaxing 14
Hebei 13
Singapore 13
Jinan 12
Falls Church 10
Hangzhou 10
Ningbo 10
Augusta 9
Ardabil 8
Leawood 8
Norwalk 8
San Mateo 8
Andover 7
Dallas 7
Helsinki 7
Munich 7
Seoul 7
Taizhou 7
Monmouth Junction 6
Mountain View 6
Ashburn 5
Auburn Hills 5
Guangzhou 5
Kunming 5
Toronto 5
Cagliari 4
Lanzhou 4
Los Angeles 4
New York 4
San Francisco 4
Changchun 3
Hefei 3
Tappahannock 3
Alghero 2
Berlin 2
Canberra 2
Cedar Knolls 2
Città Di Castello 2
Olomouc 2
Rome 2
Torino 2
Bridlington 1
Chalfont 1
Chengdu 1
Chittagong 1
Dhaka 1
Dubai 1
Edinburgh 1
Edmonton 1
Frankfurt am Main 1
Fuzhou 1
Haifa 1
Haikou 1
Huntington 1
Luxembourg 1
Messina 1
Panama City 1
Pune 1
Qingdao 1
Raleigh 1
Shanghai 1
Sofia 1
São Paulo 1
Tallinn 1
Thimphu 1
Timis 1
Vienna 1
Xian 1
Zhoushan 1
Zurich 1
Totale 1.550
Nome #
INHIBITION OF 3-HYDROXY-3-METHYLGLUTARY-COA REDUCTASE ACTIVITY AND GENE EXPRESSION BY DEHYDROEPIANDROSTERONE IN PRENEOPLASTIC LIVER NODULES 89
Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-kappa B and Mat1A genes in the early stages of rat liver carcinogenesis 82
Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain 81
Role of HSP90,CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer 76
Targeted therapies in cholangiocarcinoma: emerging evidence from clinical trials 74
Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells 71
Frequent loss of heterozygosity at the Hcr1 (Hepatocarcinogenesis resistance) locus on chromosome 10 in primary hepatocellular carcinomas from LFF1 rat strain 67
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 66
Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease 63
Experimental models to define the genetic predisposition to liver cancer 63
ROLE OF YAP SIGNALLING DEREGULATION IN THE GENETIC SUSCEPTIBILITY TO HEPATOCARCINOGENESIS, AND STEMNESS AND AGGRESSIVITY OF LIVER CANCER 59
Dependence of benzo(a)pyrene metabolism on NADPH pool in normal and glucose-6-phosphate dehydrogenase deficient human fibroblasts. 59
Inhibition of promotion and persistent nodule growth by S-adenosyl-L-methionine in rat liver carcinogenesis: role of remodeling and apoptosis 58
Effect of S-adenosyl-L-methionine on the development of preneoplastic foci and the activity of some carbohydrate metabolizing enzymes in the liver, during experimental hepatocarcinogenesis. 57
Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: a long-term study. 55
c-myc amplification in pre-malignant and malignant lesions induced in rat liver by the resistant hepatocyte model 55
Dual-Specific Phosphatase 1 Ubiquitination in Extracellular Signal-Regulated Kinase-Mediated control of Grawth in Human Hepatocellular Carcinoma 55
Phenotypic reversion of rat neoplastic liver nodules is under genetic control 53
Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: is DNA methylation involved? 53
SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis 53
Inhibition by dehydroepiandrosterone of growth and progression of persistent liver nodules in experimental rat liver carcinogenesis 52
Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis 52
Differential effects of dehydroepiandrosterone and deoxyribonucleosides on DNA synthesis and de novo cholesterogenesis in hepatocarcinogenesis in rats. 52
. Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid. 52
Protooncogene methylation and expression in regenerating liver and preneoplastic liver nodules induced in the rat by diethylnitrosamine: effect of variations of S-adenosylmethionine:S-adenosylhomocysteine ratio. 51
Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis 51
Chemopreventive N-(4-hidroxyphenyl)retinamide targets NF-kB and Mat1A genes in early stages of rat liver carcinogenesis. 50
Epigenetics of liver cancer progression: Role of transcriptional and post-transcriptional regulation of methionine adenosyltransferases in liver cancer progression. 50
Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease 50
Alterations of ornithine decarboxylase gene during the progression of rat liver carcinogenesis. 50
Transferrin and transferrin receptor gene expression and iron upteke in hepatocellular carcinoma in the rat 48
Correlation between S-adenosyl-L-methionine content and production of c-myc, c-Ha-ras, and c-Ki-ras mRNA transcripts in the early stages of rat liver carcinogenesis. 48
Role of transcriptional and postttranscriptional regulation of methionine adenosyltransferases in liver cancer progression. 48
Comparative effects of L-methionine, S-adenosyl-L-methionine and 5'-methylthioadenosine on the growth of preneoplastic lesions and DNA methylation in rat liver during the early stages of hepatocarcinogenesis 47
An expression signature of phenotipic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis 47
Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value 46
The post-transcriptional dysregulation of methionine adenosyl-transferases is crucial for the progression of rat and human liver cancer. 47° Annual Meeting of the European Association for Study of the Liver (EASL) Aprile 18-22, 2012 46
Ruolo di HSP90, CDC37 e CRM1 come modulatori dell’attività di p16 INK4A nella cancerogenesi epatica di ratto e nel carcinoma epatocellulare umano 46
Reversal by 5-azacytidine of the S-adenosyl-L-methionine-induced inhibition of the development of putative preneoplastic foci in rat liver carcinogenesis 45
Ras-driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control 44
Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype 43
The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease. 40
Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice 38
Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC. 45° Annual Meeting of the European Association for the Study of the Liver (EASL) Aprile 14-18, 2010 36
Modulation of P16INK4A activity by Hsp90, Cdc37 and CRM1 influences the progression of preneoplastic lesions in rats with different predisposition to liver cancer and the prognosis of human hepatocellular carcinoma 36
Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53 35
Reversal by 5-azacytidine of the s-adenosyl-L-methionine induced inhibition of the development of putative preneoplastic foci in rat-liver 34
Inhibition of 3-hydroxy-3- methylglutaryl-CoA reductase activity and gene expression by dehydroepiandrosterone in preneolastic liver nodules 28
Totale 2.554
Categoria #
all - tutte 11.943
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.943


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020458 0 11 44 5 47 63 136 11 58 28 52 3
2020/2021465 53 0 69 6 48 21 53 1 67 69 64 14
2021/2022270 44 1 1 5 4 7 20 11 26 22 30 99
2022/2023632 67 64 13 120 51 106 0 69 109 1 19 13
2023/2024162 29 13 1 5 19 3 0 4 0 1 22 65
2024/202530 13 17 0 0 0 0 0 0 0 0 0 0
Totale 2.554